voxelotor
Global Blood Therapeutics
[]
$gbt 8-k global blood therapeutics (10 jun, 6:10am) gbt presents positive new real-world evidence data at eha2022 congress further supporting clinical use of oxbryta (voxelotor) in sickle cell disease #gbt #8k #globalbloodtherapeutics #news
Feed of new SEC filings and other useful information for stock market investors.